AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Medical Letter on the CDC & FDA articles from May 2004

10,639 total articles

Set up an RSS feed
Close Set up an RSS feed that alerts you when new articles from Medical Letter on the CDC & FDA are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds
to find out when new articles for Medical Letter on the CDC & FDA arrive.

Medical Letter on the CDC & FDA archives from May 2004

Clostridium perfringens characterized using DNA microarray chip.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Scientists have characterized Clostridium perfringens using a single target DNA microarray chip method. According to published research from the United States, "A DNA microarray method was...

Envelope protein-based vaccine enhances delays hepatitis C virus infection.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection. "Two chimpanzees, one naive...

Co-ligand complex anchors malaria merozoites to erythrocyte invasion receptor.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- A co-ligand complex anchors Plasmodium falciparum merozoites to the erythrocyte invasion receptor band 3. "In Plasmodium falciparum malaria, erythrocyte invasion by circulating merozoites may occur...

Sulphadoxine-pyrimethamine pretreatment not recommended for malaria vaccine.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Researchers recommend discontinuing sulphadoxine-pyrimethamine pretreatment for malaria vaccination. According to recent research published in the journal Vaccine, "Combination B is a malaria...

Research response for severe acute respiratory syndrome outlined.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Scientists outline a research response for severe acute respiratory syndrome in a recent issue of the Journal of Infectious Diseases. "When severe acute respiratory syndrome (SARS) first came to...

Cardiac device firm reports 7.2% decrease in revenues.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Cardima, Inc., (CRDM), reported financial results for the fourth quarter and fiscal year ended December 31, 2003. Revenues for the fourth quarter of 2003 were $552,000, compared with $595,000 for...

FDA approval granted for ANDA for erythromycin/benzoyl peroxide.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for 3% erythromycin /...

Patients with alcohol, drug disorders more likely to have personality disorders.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The prevalence of personality disorders among patients with alcohol- and drug-use disorders is significant in the United States population, according to a new study. Very little information is...

The demon drink remains largely unaddressed by public health efforts.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- According to a forthcoming report from the World Health Organization (WHO), harm caused by alcohol almost equals that from tobacco. A news feature in the April 10, 2004, issue of Nature investigates...

IND application submitted to FDA for ToxBlox anthrax infection treatment.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- PharmAthene, Inc., has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to initiate human clinical trials of ToxBlox, a novel protein, initially known...

New evidence for whole genome linkage in bipolar disorder.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) announced that a team of researchers from Upstate Medical University, the Department of Veterans Affairs (VA), the University of Coimbra, and the Broad and Whitehead Institutes...

Leading causes of blindness for blacks and whites different.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The leading cause of blindness for white people is age-related macular degeneration (AMD), while the leading causes of blindness for black people are cataracts and glaucoma, according to new research....

Loss of insulin-like growth factor imprinting linked to colon cancer.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Loss of insulin-like growth factor-II imprinting plays role in colorectal adenomas in women. "Loss of imprinting (LOI) of insulin-like growth factor-II (IGF-II) may be an inherited epigenetic trait...

Health food store advice may ignore federal safety advisories on supplements.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Advice that consumers receive at health food stores may ignore federal safety advisories on diet supplements and herbal products. "In early 2002, the U.S. Food and Drug Administration (FDA) and...

Policymakers' views on dengue fever and need for dengue vaccines outlined.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Researchers outline policymakers' views on dengue fever/dengue hemorrhagic fever and the need for dengue vaccines in four southeast Asian countries in a recent issue of the journal Vaccine. ...

Elderly get tips to beat back the blues.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Older adults can learn to beat back depression through problem solving, exercise and social activity, according to a Seattle study. After 1 year, study participants were much more likely than others...

Pre-IND meeting on diabetic peripheral neuropathy formulation announced.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The Quigley Corporation (QGLY) announced that Quigley Pharma completed its first meeting at the U.S. Food and Drug Administration (FDA) prior to submitting the company's Investigational New Drug (IND)...

U.S. patent granted for high throughput drug screening using zebrafish.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Phylonix announced the recent award of Patent No. 6,656,449, "Methods of Screening Agents for Activity Using Teleosts," by the U.S. Patent and Trademark Office, which includes claims for performing drug...

GMP Cos. announces availability of Lifesync Wireless ECG System.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- GMP Cos., Inc., a company that acquires, develops, and commercializes pharmaceutical, diagnostic, and medical-device technologies, announced the availability of the LifeSync Wireless ECG System,...

Company announces U.S. Army contract for Personal Information Carrier.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- InHand Electronics, Inc., a provider of low-power handheld- and wireless-device platform technologies, announced it has received a contract from the United States Army to develop a new electronic...

D.C. agency accused of hiding lead in water.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The District of Columbia's Water and Sewer Authority (WASA) "tried to hide extraordinarily high levels of lead" in the water and put children and pregnant women at risk, a mother testified on April 7,...

Organic pollutants detected in giant mussels off the Chilean coast.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Organic pollutants were detected in giant mussels off the coast of Chili. "A comparative quantitative analysis was made on the contents of organochlorines (OCh) and polycyclic aromatic hydrocarbons...

Comprehensive study: We know little about environment's effects on kids.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- An unprecedented effort to compile everything the medical and scientific community knows about how children differ from adults in terms of their biologic vulnerability to environmental agents such as...

Data augmentation helps estimate Legionella subclinical infection rate.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Data augmentation can be used to improve estimates of subclinical Legionella infection. "Infections with Legionella bacteria can cause a potentially lethal form of pneumonia known as legionnaires'...

Physicians, nurses and U.S. government release new food-borne illness guide.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Americans' vulnerability to food-borne illness has been highlighted by large outbreaks over the last 2 years. To increase awareness, a new educational guide for health care professionals on how to...

Waterborne norovirus outbreak in Sweden described.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- A Swedish norovirus outbreak - the first in which genotyping was used to identify the source of the pathogen - has been described. "From May through June 2001, an outbreak of acute gastroenteritis...

Evidence support mechanistic link between heat shock and oxidative stress.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Evidence supports a mechanistic link between heat shock and oxidative stress. "In spite of ongoing research efforts, the specific mechanism(s) of heat-induced alterations in the cellular response to...

Positive phase III clinical results achieved with Polyphenon E Ointment.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The German-American biotech company MediGene, AG, (MDG) has achieved excellent results in a European phase III trial of the Polyphenon E Ointment for the treatment of genital warts. The...

p21-activated kinase 4 has direct interaction with PDZ-RhoGEF.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- p21-activated kinase 4 has direct interaction with PDZ-RhoGEF, a G protein-linked Rho guanine exchange factor. "Rho GTPases regulate a wide variety of cellular processes, ranging from actin...

Cheaper AIDS drugs to be available in U.N.-supported nations.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Former President Bill Clinton's foundation said April 6, 2004, that the special drug prices it has obtained for HIV/AIDS sufferers in some countries are being extended to all poor nations covered by...

FDA approves OraQuick Rapid HIV Antibody Test for use with oral fluid.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- OraSure Technologies, Inc., (OSUR), has received U.S. Food and Drug Administration (FDA) approval of its OraQuick Rapid HIV Antibody Test for use with oral fluid. This approval makes the test the...

Noninvasive assay for P. carinii pneumonia monitoring developed.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- A novel molecular assay enables noninvasive monitoring of Pneumocystis carinni pneumonia. In a recent study from the United States, the progression of P. carinii pneumonia was "temporally monitored...

CDC grants $21 million to enhance HIV prevention in communities of color.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Regional and national organizations dedicated to preventing HIV in communities of color will receive $21 million from the U.S. Centers for Disease Control and Prevention (CDC). The awards go to 27...

Enrollment concluded in Taxus V trial; FDA clears Contour SE.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that it has concluded enrollment in its Taxus V de novo lesion clinical trial and that its Contour SE embolic agent for the treatment of uterine fibroids...

FDA issues 510(k) clearance for D-Stat Dry 3x3 Hemostatic Bandage.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Vascular Solutions, Inc., (VASC) has received 510(k) clearance by the U.S. Food and Drug Administration for its D-Stat Dry 3x3 hemostatic bandage, a new version of the company's original D-Stat Dry...

Cell culture and animal models for human viral hepatitis reviewed.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Scientists review the cell culture and animal models available for human viral hepatitis in a recent issue of Hepatology Research. "Human hepatitis viruses are currently the subjects of intense...

Prevalence of hepatitis C high among homeless of Oxford, England.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The prevalence of hepatitis C is high among the homeless community of Oxford, England. According to a study from England, "Hepatitis C (HCV) is an emerging health concern across the world, with 170...

Acute immune response to filarial parasites characterized by Th1 cytokines.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Contrary to conventional wisdom, pro-inflammatory cytokines are predominant during the early immune response to filarial parasites. According to recent research from the United States, "[a]lthough...

Did West Nile virus infection fell Alexander the Great?
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Could West Nile virus infection have felled Alexander the Great? According to scientists in the United States, "Alexander the Great died in Babylon in 323 BC," following a "2-week febrile illness....

FDA approves new presentations of Gonal-f to treat infertility.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Serono, Inc., (SRA) announced that the U.S. Food and Drug Administration (FDA) has approved new presentations of Gonal-f (follitropin alfa for injection), including a 450 IU multi-dose vial and a 75 IU...

Alcohol limit for drunk driving should be much lower.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The alcohol limit for drunk driving should be much lower, argues a researcher. In the United Kingdom, United States, Canada, South Africa, and Sri Lanka the legal blood alcohol limit is 0.08 mg per...

Bright clothing and white helmets cut motorcycle deaths.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Wearing reflective clothing, a white or light colored helmet, and using headlights during the day can reduce serious injuries or death from motorcycle crashes by up to one-third, according to research...

Leishmania induce Myd88-dependent maturation of splenic dendritic cells.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Leishmania donovani and other Leishmania species induce Myd88-dependent in vivo maturation of splenic dendritic cells. According to recent research published in the journal Infection and Immunity,...

Treatment of cutaneous leishmaniasis among travelers reviewed.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Researchers review the treatment of cutaneous leishmaniasis among travelers in a recent issue of the Journal of Antimicrobial Chemotherapy. "Leishmaniasis is endemic in 88 countries on five...

Company completes NDA for clofarabine.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- ILEX Oncology, Inc., (ILXO) has submitted the final section of its new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for clofarabine for the treatment of refractory or relapsed...

Listeria monocytogenes blood agar effective for microorganism isolation.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Listeria monocytogenes blood agar is effective for microorganism isolation. According to a study from Ireland, "A year-long survey of two Northern Ireland milk processing plants for Listeria...

Riboprint analysis of applied to Listeria monocytogenes isolates.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Researchers applied riboprint analysis of applied to Listeria monocytogenes isolates. "Listeria monocytogenes is a widespread human and annual pathogen. Despite the potential value of ribotyping for...

CDC announces new awards for Lyme disease research.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The U.S. Centers for Disease Control and Prevention (CDC) has announced that more than $3.5 million will be awarded to 10 institutions for new research on Lyme disease. The studies are designed to...

NDA submitted for SnET2-PDT to treat wet AMD.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Miravant Medical Technologies (MRVT), a pharmaceutical development company specializing in PhotoPoint photodynamic therapy (PDT), has submitted a new drug application (NDA) to the U.S. Food and Drug...

Activity of Plasmodium rhoptry-associated protein peptides reported.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Researchers determine the specific erythrocyte binding capacity and biological activity of Plasmodium falciparum-derived rhoptry-associated protein 1 peptides. "Rhoptry-associated protein 1 (RAP1)...

Antibodies to malaria peptide mimics inhibit invasion of erythrocytes.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Antibodies to malaria peptide mimics inhibit Plasmodium falciparum invasion of erythrocytes. According to a study from Australia and the Netherlands, "Apical membrane antigen 1 (AMA1) is expressed...

Erythrocyte-binding antigen of P. falciparum not promising vaccine candidate.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The erythrocyte-binding antigen 175 of Plasmodium falciparum is not a promising candidate for an effective malaria vaccine. "Region II of the 175-kDa erythrocyte-binding antigen (EBA-175RII) of...

Merozoite surface proteins differ in ability to protect against malaria.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria. "Previously, we described the isolation of the...

Branded drug-makers prepare for the inevitable.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Impax Laboratories announced that the U.S. Food and Drug Administration (FDA) has granted final approval to begin producing a generic version of Wellbutrin SR 150 mg tablets developed by GlaxoSmithKline...

Higher spending does not necessarily translate into better care, study finds.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Higher spending for Medicare does not necessarily translate into better care, says a study that found patients got less effective treatment in states that spent more on medical specialists. ...

Ae. aegypti in Brazil highly susceptible to dengue and yellow fever viruses.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Aedes aegypti in Brazil are highly susceptible to dengue and yellow fever viruses. These mosquitos were "eliminated from Brazil in 1955, but re-infested the country in the 1970s," scientists there...

Light-traps are alternative method for sampling adult anophelines.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Modified CDC miniature light-traps are an alternative method for sampling adult anophelines (Diptera: Culicidae) in the National Mosquito Surveillance Program in India. According to recent research...

Phase III pivotal trial for STR begins.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- NeoRx Corp. (NERX) has opened the phase III clinical trial of its lead cancer therapeutic, STR (Skeletal Targeted Radiotherapy), to patient enrollment. NeoRx is developing STR for use with high-dose...

Antimicrobial resistance on the rise in American hospitals.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Antimicrobial resistance in becoming increasingly common in American nosocomial infections. Scientists in the United States "assessed resistance rates and trends for important...

U.S. considers Food Guide Pyramid changes.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The suggestions range from wacky to reasonable, but plenty of people have ideas about how to revamp the U.S. Food Guide Pyramid, that iconic graphic that supposedly guides how people eat. An artist...

FDA approves LAP-BAND VG System; product hits market.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- INAMED Health, a division of INAMED Corp. (IMDC) and the developer of the BioEnterics LAP-BAND System, announced market introduction and U.S. Food and Drug Administration (FDA) approval of a product...

Positive phase III data reported for PREOS.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- NPS Pharmaceuticals, Inc., (NPSP) announced that its pivotal phase III study of PREOS successfully met the primary endpoint of reducing the incidence of new or worsened vertebral fractures in...

Enterotoxin-producing E. coli O169:H41 outbreaks summarized.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Outbreaks of enterotoxin-producing Escherichia coli O169:H41 in the United States are summarized in a recent issue of Emerging Infectious Diseases. According to recent research from the United...

Initial commercialization of Oxycodone 80 mg announced.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Teva Pharmaceutical Industries Ltd. (TEVA) announced that subsequent to the approval of its abbreviated New Drug Application dated March 24, 2004, the U.S. Food and Drug Administration now regards the...

Details reported from FDA meeting on oxymorphone NDAs.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Endo Pharmaceuticals Holdings, Inc., (ENDP) announced the outcome of its recent meeting with the U.S. Food and Drug Administration (FDA) to review its proposed strategy for addressing the questions and...

Results of meeting with FDA on bicifadine reported.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) announced that on March 30, 2004, it participated in an end of phase II meeting with representatives of the U.S. Food and Drug Administration's (FDA) Division of...

Persistent parvovirus B19 infection without chronic anemia reported.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Persistent parvovirus B19 infection without the development of chronic anemia has been reported in HIV-infected and -uninfected children. According to a study from the United States, "We evaluated...

Kos files suit for infringement of new Niaspan patent.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) announced that it has filed a lawsuit in the Southern District Court of New York against Barr Laboratories, Inc., (BRL) for infringement of U.S. patent no. 6,676,967,...

Study reports 90 million Americans have limited health literacy.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Nearly half of all American adults - 90 million people - have difficulty understanding and using health information, and there is a higher rate of hospitalization and use of emergency services among...

FDA grants orphan drug designation for microplasmin in pediatric eye surgery.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- ThromboGenics Ltd. has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for use of its compound microplasmin in pediatric eye surgery, to treat retinal disorders that...

Assay results for pertussis standardized.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- The European Sero-Epidemiology Network reports the standardization of assay results for pertussis. According to a study from an international team of researchers, "A standardization process was...

Developing country perspective on vaccine-associated paralytic polio released.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- A researcher has published a developing country perspective on vaccine-associated paralytic poliomyelitis in a recent issue of the Bulletin of the World Health Organization. "When the Expanded...

New Hampshire governor unveils state Internet link to Canadian pharmacy.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Insisting that profits, not safety, are fueling the debate over prescription drugs, New Hampshire Gov. Craig Benson has unveiled a link on the official state website to a Canadian pharmacy that exports...

Study: PPOs employ diverse approaches to preventive care for patients.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Preferred provider organizations (PPOs) and medical management organizations (MMOs) employ diverse approaches to preventive care services, according to a report released by URAC. The study was...

Public smoking bans may cut heart attacks.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Smoke-free laws may be linked with a rapid fall in the number of heart attacks, according to new research. Previous studies have shown that people living or working in an environment polluted with...

FDA approval granted for Ketek (telithromycin) tablets.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Aventis (AVE) announced that the U.S. Food and Drug Administration (FDA) has approved Ketek (telithromycin) tablets to treat acute exacerbation of chronic bronchitis; acute bacterial sinusitis; and mild...

Sexually transmissible infections other than HIV reviewed.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- A researcher reviews sexually transmissible infections other than HIV in a recent issue of the Lancet. According to recent research from Australia, "Sexually transmitted infections (STIs) are...

Shigella flexneri 2a vaccine protects against shigellosis symptoms.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- A live, attenuated Shigella flexneri 2a vaccine (SC602) prevented severe shigellosis symptoms in North American volunteers. According to recent research from the United States, "We report the first...

Fresh apple peel extract may have potential chemoprotective effects.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Fresh apple peel extract may have chemoprotective effects. "Consumption of fruits and vegetables has been associated with a low incidence of cancers and other chronic diseases. Previous studies...

Nursing home patient dies from 'flesh-eating' bacteria.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- A nursing home patient in Gainesville, Georgia, has died of an ailment commonly known as "flesh-eating bacteria," and the illnesses of two others are under investigation, state health officials said....

HuMax-CD4 gets fast track status.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Genmab A/S (GEN) announced that HuMax-CD4 has been designated a fast track product by the U.S. Food and Drug Administration. This designation covers patients with cutaneous T cell lymphoma (CTCL)...

Agreement received from FDA on phase III protocol for Altropane.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Boston Life Sciences, Inc., (BLSI) announced that the company has reached a binding agreement from the U.S. Food & Drug Administration (FDA) regarding the company's protocol design for a new phase III...

Mycobacterium tuberculosis cultures may represent cross contamination.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- Cultures positive for Mycobacterium tuberculosis may represent cross contamination. "Many clinicians and laboratory personnel are unaware that a culture positive for Mycobacterium tuberculosis may...

BCG vaccination not associated with positive tuberculin test.
May 2, 2004... 2004 MAY 2 - (NewsRx.com & NewsRx.net) -- BCG vaccination was not associated with a positive tuberculin test in children in Brazil. According to published research from Brazil, "This case-control study analyses the association between the...

More articles from Medical Letter on the CDC & FDA: 1 | 2 | 3 | 4 | 5 | 6
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA